Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Patil

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Indian Journal of Cancer|December 5, 2017
Retrospective analysis of palliative metronomic chemotherapy in head and neck cancerV M Patil, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2019
DPYD Mutation in Indian PatientsV M Patil, A Chougule, V Noronha, et al.
Indian Journal of Cancer|June 21, 2014
Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer centerV M Patil, S Chakraborty, P K Shenoy, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2017
Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual ParadigmV Noronha, S Zanwar, A Joshi, et al.
Indian Journal of Cancer|December 5, 2017
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patientsS Zanwar, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2018
Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck CancerV M Patil, V Noronha, A Joshi, et al.
Indian Journal of Cancer|March 1, 2017
Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteriaA Joshi, A Ramaswamy, V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2015
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?S Kane, V M Patil, A Joshi, et al.
Indian Journal of Cancer|May 10, 2017
Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysisS Zanwar, A Joshi, V Noronha, et al.
Indian Journal of Cancer|February 5, 2016
An audit of febrile neutropenia cases from a rural cancer center in IndiaV M Patil, S Chakarborty, M S Kumar, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Indian Journal of Cancer|December 5, 2017
Retrospective analysis of palliative metronomic chemotherapy in head and neck cancerV M Patil, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2019
DPYD Mutation in Indian PatientsV M Patil, A Chougule, V Noronha, et al.
Indian Journal of Cancer|June 21, 2014
Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer centerV M Patil, S Chakraborty, P K Shenoy, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2017
Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual ParadigmV Noronha, S Zanwar, A Joshi, et al.
Indian Journal of Cancer|December 5, 2017
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patientsS Zanwar, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2018
Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck CancerV M Patil, V Noronha, A Joshi, et al.
Indian Journal of Cancer|March 1, 2017
Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteriaA Joshi, A Ramaswamy, V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2015
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?S Kane, V M Patil, A Joshi, et al.
Indian Journal of Cancer|May 10, 2017
Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysisS Zanwar, A Joshi, V Noronha, et al.
Indian Journal of Cancer|February 5, 2016
An audit of febrile neutropenia cases from a rural cancer center in IndiaV M Patil, S Chakarborty, M S Kumar, et al.
Pageof 6